Sectors
SBFM
Sunshine Biopharma, Inc.
1.19
2 x 1.15
6 x 1.32
bid
ask
-
0.03
2.87%
09:38 AM
timesize
| Ytd | -90.37% | |
| 1y | -91.71% |
1.18
day range
1.21
1.10
52 week range
24.30
| Open | 1.21 | Prev Close | 1.22 | Low | 1.18 | High | 1.21 | Mkt Cap | 2.82M |
| Vol | 41.10K | Avg Vol | 1.89M | EPS | -6.08 | P/E | -0.19 | Forward P/E | 0.02 |
| Beta | 1.16 | Short Ratio | 0.39 | Inst. Own | 1.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.94 | 200-d Avg | 9.57 | 1yr Est | 300.00 |
| Income Statement | |||
| Total Revenue | 8.09M | ||
| Revenues (USD) | 8.09M | ||
| Cost of Revenue | 5.91M | ||
| Gross Profit | 2.18M | ||
| Operating Expenses | 3.58M | ||
| Research and Development Expense | 31.72K | ||
| Selling, General and Administrative Expense | 3.34M | ||
| Operating Income | -1.40M | ||
| Net Income | -1.24M | ||
| Net Income Common Stock | -1.24M | ||
| Net Income Common Stock (USD) | -1.24M | ||
| Consolidated Income | -1.24M | ||
| Earnings per Basic Share | -2.50 | ||
| Earnings per Basic Share (USD) | -2.50 | ||
| Earnings per Diluted Share | -2.50 | ||
| Earning Before Interest & Taxes (EBIT) | -1.24M | ||
| Earning Before Interest & Taxes (USD) | -1.24M | ||
| Weighted Average Shares | 490.59K | ||
| Weighted Average Shares Diluted | 490.59K | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.98M | ||
| Cash and Equivalents (USD) | 6.98M | ||
| Trade and Non-Trade Receivables | 4.01M | ||
| Current Assets | 24.78M | ||
| Property, Plant & Equipment Net | 1.23M | ||
| Total Assets | 27.93M | ||
| Debt Current | 209.23K | ||
| Total Debt | 744.84K | ||
| Current Liabilities | 5.88M | ||
| Debt Non-Current | 535.61K | ||
| Total Liabilities | 6.41M | ||
| Accumulated Retained Earnings (Deficit) | -76.26M | ||
| Accumulated Other Comprehensive Income | -343.31K | ||
| Shareholders Equity | 21.52M | ||
| Shareholders Equity (USD) | 21.52M | ||
| Assets Non-Current | 3.15M | ||
| Total Debt (USD) | 744.84K | ||
| Goodwill and Intangible Assets | 1.92M | ||
| Inventory | 13.17M | ||
| Liabilities Non-Current | 535.61K | ||
| Trade and Non-Trade Payables | 5.40M | ||
| Tax Liabilities | 268.28K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 76.86K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.18M | ||
| Capital Expenditure | -5.13K | ||
| Net Cash Flow from Investing | -104.52K | ||
| Net Cash Flow from Operations | -2.07M | ||
| Effect of Exchange Rate Changes on Cash | -33.68K | ||